Deals
Deals dated after 30 September 2026 are still being collected.
Columns
3 of 3 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2026 | United Dogecoin | – | Shuttle Pharmaceutical Holdings | Merger | Financial adviser to Shuttle Pharmaceutical Holdings (acquirer) | Announced | – | Crypto & Web3+1 | Sullivan & Worcester (buy-side) | Shuttle Pharmaceutical Holdings and United Dogecoin merger |
| Apr 2026 | Shuttle Pharmaceutical Holdings | – | – | Placement | Placement agent to the lead managers | Announced | 11.0 | Crypto & Web3+1 | McDermott Will & Schulte (lead manager) | Shuttle Pharmaceutical Holdings placement |
| Dec 2025 | Apimeds Pharmaceuticals US | – | – | Convertible | Placement agent to the lead managers | Completed | 10.9 | Pharma+1 | Nelson Mullins Riley & Scarborough (issuer) | Apimeds Pharmaceuticals US equity raising |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Repeat clients
- Shuttle Pharmaceutical Holdings2 deals